
Ilytica is a company revolutionizing molecular diagnostics with its digital molecular analytics platform, which leverages single molecule imaging and machine learning to deliver accurate results in under 5 minutes using just a microscope. Their technology analyzes millions of individual single molecule assays, separating signal from noise to achieve significant improvements over conventional methods. This approach enables miniaturization, allowing complex tests to be performed outside traditional lab settings, and offers speed, applicability across various sample types (blood, urine, saliva), and cost-effectiveness. Ilytica's patent-pending technology is a paradigm shift in biomolecular analysis, offering extreme error tolerance and the potential for mobile diagnostics.

Ilytica is a company revolutionizing molecular diagnostics with its digital molecular analytics platform, which leverages single molecule imaging and machine learning to deliver accurate results in under 5 minutes using just a microscope. Their technology analyzes millions of individual single molecule assays, separating signal from noise to achieve significant improvements over conventional methods. This approach enables miniaturization, allowing complex tests to be performed outside traditional lab settings, and offers speed, applicability across various sample types (blood, urine, saliva), and cost-effectiveness. Ilytica's patent-pending technology is a paradigm shift in biomolecular analysis, offering extreme error tolerance and the potential for mobile diagnostics.